References of "Current Opinion in Investigational Drugs (London, England : 2000)"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailStrontium Ranelate (Fujisawa/Servier)
Jupsin, Isabelle ULg; Collette, Julien ULg; Henrotin, Yves ULg et al

in Current Opinion in Investigational Drugs (London, England : 2000) (2005), 6(4), 435-44

Strontium ranelate (PROTELOS), a divalent strontium salt, has been developed and launched by Servier for the treatment of osteoporosis. Fujisawa Pharmaceutical is developing the drug in Japan; in November ... [more ▼]

Strontium ranelate (PROTELOS), a divalent strontium salt, has been developed and launched by Servier for the treatment of osteoporosis. Fujisawa Pharmaceutical is developing the drug in Japan; in November 2004, phase II Japanese trials were ongoing. [less ▲]

Detailed reference viewed: 34 (5 ULg)